Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study (NCT07313072) | Clinical Trial Compass
Not Yet RecruitingPhase 2
Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
10 participantsStarted 2026-03
Plain-language summary
To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: Age ≥ 18 years;
* Presence of nail psoriasis in at least one fingernail or toenail;
* Patients not using systemic medication, or without adequate response to systemic medication after at least 6 months of use;
* Ability to read, understand, and sign the Informed Consent Form (ICF) and the Consent Form for Images, Presentations, and Scientific Publications.
Exclusion Criteria: Pregnant or breastfeeding women or those planning to become pregnant during the study period;
* History of sensitivity to any components of the study product;
* Initiation of systemic medication for nail psoriasis less than six months prior.